Many investors seemed to view Nvidia's decision to maintain its stake in Recursion as a vote of confidence in the company.

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

Pharma stocks reacted sharply to concerns that the US might impose tariffs on pharmaceutical imports, causing the Nifty ...

NATCO Pharma stock has declined 34% over six days due to disappointing Q3 FY25 results, including a 37.4% revenue drop and a ...

Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its ...

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

Stock analysts at StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) in a research report issued on Saturday. The firm set a “hold” rating on the ...

Aside from reciprocal tariffs, US President Trump has teased imposing tariffs on several import heavy sectors, including ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a pharmaceutical company with a market capitalization of $72.6 million, has ...